...入治疗是原发性肝癌及继发性肝癌非手术疗法的重要组成部分,包括肝动脉灌注化疗(HAI)和栓塞(HAE)以及门静脉灌注化疗(IPIC),它们在治疗不能手术切除的中晚期肝癌及转移癌上已经取得了良好的效果,已被公认为是肝癌及转移癌非手术疗法的首选方法,经肝动...
基于24个网页-相关网页
...-cnki翻译助手 )经肝动脉灌注化疗(transcatheter arterial chemotherapy,TAC)联合门静脉灌注化疗(portal vein chemotherapy,PVC)对大鼠种植性肝癌的治疗效果; 短句来源 cases of advanced gastric..
基于4个网页-相关网页
目的 研究肝动脉化疗栓塞基础上经皮经肝门静脉灌注化疗治疗晚期肝癌的疗效。
Objective To study the effect of transcatheter chemoembolization(TACE) plus percutaneous transhepatic portochemotherapy(PTP)for the treatment of primary liver cancer(PLC).
结论中晚期不能切除的原发性肝癌使用肝动脉、门静脉双重插管灌注化疗,可以改善临床症状、延长存活期。
Conclusion Double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma may ameliorate symptoms and prolong survival time.
目的探讨肝动脉、门静脉双重插管区域灌注化疗在中晚期不能切除原发性肝癌应用方法及临床疗效。
Objective To explore the curative effect of double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma.
应用推荐